Gilead Sciences (GILD) reachead $85.21 at the closing of the latest trading day, reflecting a +0.92% change compared to its last close.

Genomics, Inc. , a leader in single cell and spatial biology, today announced preliminary select results for the third quarter ended September 30, ...

The Twiga partnership between Barrick Gold Corporation and the Tanzanian government is contributing 51% of the government's revenue from the extractive industry, according to the latest report of the ...

As part of the Middle East Medicinal Plant Project (MEMP), she has been intrigued ... agriculture at the Arava Institute of Environmental Science (AIES), lives on Kibbutz Ketura in the Arava.

Ahead of the Budget, the chancellor is grappling with how to address a significant fiscal black hole while driving up Britain’s economic growth. One answer can be found in Labour’s election manifesto, ...

The analyst projects peak sales for COBENFY to reach ... focusing on stocks such as Eli Lilly & Co, Novo Nordisk, and Gilead Sciences. In another report released yesterday, Wells Fargo also ...

The Business & Finance CFO 100 Index 2024, in association with Sia Partners, recognises the top 100 Chief Financial Officers ...

After falling short in a confirmatory clinical trial, Gilead Sciences has decided to withdraw Trodelvy as a bladder cancer treatment in the U.S. The California biotech announced the decision ...

Gilead Sciences (GILD) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some ...